Streetbeat News

Stock Prices

BEP

Credit Suisse has maintained its Outperform rating for Brookfield Renewable (NYSE:BEP) and raised its price target from $40.00 to $41.50. Shares of Brookfield Renewable are currently trading down 0.5% at $29.63 per share.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 5:01 pm

BHP

KLAC

RIG

CNBC's Halftime Report discussed final trades, highlighting BHP Group, KLA Corp, and Transocean as stocks to watch.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 5:01 pm

FITB

Citigroup has maintained its Neutral rating for Fifth Third Bancorp (NASDAQ:FITB) and lowered its price target from $30.00 to $28.00. FITB shares are currently trading at $26.57, up 2.39% over the last 24 hours.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 5:01 pm

CSTL

BTIG maintains its Buy rating for Castle Biosciences (NASDAQ:CSTL) but lowers its price target from $38.00 to $30.00. Shares of CSTL are trading down 1.98% at $13.40 per share.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 5:01 pm

ALGT

Deutsche Bank upgraded its rating of Allegiant Travel (NASDAQ:ALGT) to Buy with a price target of $145.00, up from $110.00. Shares of Allegiant Travel are trading up 1.42% at $116.42 per share.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 5:00 pm

CRWD

Mizuho maintains its Buy rating for CrowdStrike Holdings (NASDAQ:CRWD) and raises its price target from $175.00 to $180.00. CrowdStrike's shares are trading up 1.02% at $155.53, with a potential 15.73% increase if the price target is reached.

Portfolio Pulse from Benzinga Insights

June 15, 2023 | 5:00 pm

BHP

KLAC

RIG

CNBC's Halftime Report discussed final trades, mentioning BHP Group, KLA Corp, and Transocean as stocks to watch.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 5:00 pm

BLK

COIN

MSTR

BlackRock, the world's largest asset manager, is reportedly nearing an application for a Bitcoin ETF despite increased SEC scrutiny on the crypto industry and Bitcoin's price below $25K. The company has been increasing its exposure to Bitcoin through its 8.10% stake in MicroStrategy.

Portfolio Pulse from Jose Rodrigo Safdiye

June 15, 2023 | 4:56 pm

ALDX

Aldeyra Therapeutics (NASDAQ:ALDX) reported positive topline results from the Phase 3 INVIGORATE-2 trial of 0.25% reproxalap ophthalmic solution for allergic conjunctivitis. The trial achieved statistical significance for the primary endpoint and all secondary endpoints. ALDX shares are up 11% at $11.60.

Portfolio Pulse from Vandana Singh

June 15, 2023 | 4:52 pm

HUM

Humana shares are trading higher as health insurers rebound after falling on Wednesday.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 4:50 pm